Management of Oral and Maxillofacial Infection. Where Shall We Start?
نویسندگان
چکیده
منابع مشابه
Where are we and where shall we go in nursing and emergencies?
1. Manager, Health and Nutrition Tracking Service, Health Action in Crisis Cluster, World Health Organization, and Henrik H. Bendixen Professor of Clinical International Nursing, School of Nursing, Columbia University, New York, New York USA 2. Technical Officer, Health Action in Crisis Cluster, World Health Organization, and Member of the Faculty of Public Health Medicine, Royal College of Phy...
متن کاملPreregistration: when shall we start the real discussion?
tion studies, in the past 2 years guidance for drafting research protocols have been published (PRISMA-P and SPIRIT checklist, respectively), along with dedicated websites (http://www.crd.york. ac.uk/PROSPERO/ and http://www.clinicaltrials.gov, respectively). Though the endorsement by scientists of such guidance checklists is impressive, no one guidance for observational epidemiologic study pro...
متن کاملInformation literacy assessment: Where do we start?
Information Literacy Assessment: Where do we start? Users may access full items free of charge; copies of full text items generally can be reproduced, displayed or performed and given to third parties in any format or medium for personal research or study, educational or notforprofit purposes without prior permission or charge, provided: • The authors, title and full bibliographic details is ...
متن کاملWhere Do We Start? Building Consensus on Drivers of Health Sector Corruption in Nigeria and Ways to Address It
Background Corruption is widespread in Nigeria’s health sector but the reasons why it exists and persists are poorly understood and it is often seen as intractable. We describe a consensus building exercise in which we asked health workers and policy-makers to identify and prioritise feasible responses to corruption in the Nigerian ...
متن کاملAcute promyelocytic leukemia: where did we start, where are we now, and the future
Historically, acute promyelocytic leukemia (APL) was considered to be one of the most fatal forms of acute leukemia with poor outcomes before the introduction of the vitamin A derivative all-trans retinoic acid (ATRA). With considerable advances in therapy, including the introduction of ATRA initially as a single agent and then in combination with anthracyclines, and more recently by developmen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Dental Health, Oral Disorders & Therapy
سال: 2017
ISSN: 2373-4345
DOI: 10.15406/jdhodt.2017.07.00242